How to think about boosters in light of this week's Pfizer and Moderna news
CNN
Pfizer and BioNTech announced Tuesday that they're beginning a clinical trial for an Omicron-specific Covid-19 vaccine, and Moderna revealed Wednesday that it has entered Phase 2 of its own trial of a vaccine that targets the variant, which is by far the dominant one in the United States right now.
About 50% of eligible Americans have received a booster shot, according to the US Centers for Disease Control and Prevention, but the Pfizer and Moderna news might raise questions regardless. For those who have yet to get inoculated, should they wait until there is an Omicron-specific vaccine? What if someone has already had Covid-19 during the Omicron surge, do they still need a booster? And what does this mean for people who've already gotten a booster, or those who received the one-dose Johnson & Johnson vaccine and then subsequently got a dose of another kind?
President Joe Biden asserted Friday that Hamas has been degraded to a point where it can no longer carry out the type of attack that launched the current 8-month conflict in Gaza, laying out a three-phase proposal Israel has submitted to wind down the grinding crisis as he declared, “It’s time for this war to end.